Simultaneous newborn screening for sickle cell disease, biotinidase deficiency, and hereditary tyrosinemia type 1 with an optimized tandem mass spectrometry protocol.

Ann Hematol

Newborn Screening Laboratory, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Published: August 2022

Download full-text PDF	Source
http://dx.doi.org/10.1007/s00277-022-04811-0	DOI Listing

Publication Analysis

simultaneous newborn

newborn screening

screening sickle

sickle cell

cell disease

disease biotinidase

biotinidase deficiency

deficiency hereditary

hereditary tyrosinemia

tyrosinemia type

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!